This webinar will feature speakers from Eli Lilly and Company, Gilead, and Pfizer. They will come together to represent their experiences in establishing medical information strategy, content and operations for Emergency Use Authorization (EUA) products for the prevention and treatment of COVID-19. Speakers will share their experiences readying their organizations to answer medical information inquiries from a resourcing, customer, and channels and scientific content perspective. They will discuss unique opportunities to partner both internally and externally to ensure customer information needs are met through a variety of channels. Finally, speakers will review what lessons they learned during their journeys.